Ensartinib in Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients: Updated Data

被引：0
|
作者：
Leal, T. [1 ]
Wakelee, H. [2 ]
Reckamp, K. [3 ]
Waqar, S. [4 ]
Patel, S. [5 ]
Blumenschein, G. [6 ]
Neal, J. [2 ]
Harrow, K. [7 ]
Holzhausen, A. [7 ]
Liang, C. [7 ]
Dukart, G. [7 ]
Horn, L. [8 ]
机构：
[1] Univ Wisconsin, Madison, WI USA
[2] Stanford Canc Inst, Stanford, CA USA
[3] City Hope Comprehens Canc Ctr, Duarte, CA USA
[4] Washington Univ, St Louis, MO USA
[5] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[7] Xcovery Holdings Inc, Palm Beach Gardens, FL USA
[8] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 09期
关键词：
ALK; ensartinib; NSCLC; CNS;
D O I：
10.1016/j.jtho.2018.07.028
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PD.1.03
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [1] Intracranial activity of ensartinib in patients with anaplastic lymphoma kinase positive (ALK plus ) non-small cell lung cancer (NSCLC)
    Wakelee, H.
    Reckamp, K. L.
    Leal, T. A.
    Patel, S. P.
    Blumenschein, G.
    Shum, E.
    Nieva, J.
    Oxnard, G.
    Sanborn, R. E.
    Waqar, S.
    Zeman, K.
    Dukart, G.
    Harrow, K.
    Liang, C.
    Holzhausen, A.
    Horn, L.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [2] Rash and Efficacy in Anaplastic Lymphoma Kinase Positive (ALK plus ) Non-Small Cell Lung Cancer Patients Treated with Ensartinib
    Wakelee, H.
    Reckamp, K.
    Leal, T.
    Chiappori, A.
    Waqar, S.
    Zeman, K.
    Neal, J.
    Liang, C.
    Harrow, K.
    Holzhausen, A.
    Zhou, J.
    Selvaggi, G.
    Horn, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S566 - S566
  • [3] Post-Ensartinib Outcomes in Refractory Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)
    Kim, H.
    Vu, P.
    Harrow, K.
    Liang, C.
    Selvaggi, G.
    Weihe, E.
    Mitchell, W.
    Bazhenova, L.
    Patel, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S577 - S578
  • [4] Treatment Sequencing in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer (NSCLC) in Japan
    Goto, Y.
    Yamamoto, N.
    Masters, E.
    Kikkawa, H.
    Mardekian, J.
    Wiltshire, R.
    Togo, K.
    Ma, H.
    Ohe, Y.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S878 - S879
  • [5] eXalt3: Phase 3 randomized study comparing ensartinib to crizotinib in anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) patients
    Horn, L.
    Wu, Y-L.
    Reck, M.
    Liang, C.
    Tan, F.
    Harrow, K.
    Oertel, V.
    Dukart, G.
    Mok, T. S. K.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (04) : S116 - S116
  • [6] eXalt3: Phase 3 randomized study comparing ensartinib to crizotinib in anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) patients
    Horn, Leora
    Wu, Yi-Long
    Reck, Martin
    Wakelee, Heather A.
    Liang, Chris
    Tan, Fenlai
    Harrow, Kimberly
    Oertel, Vance
    Dukart, Gary
    Mok, Tony
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] EXalt3: A phase III study of ensartinib (X-396) in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC)
    Horn, L.
    Wu, Y-L.
    Reck, M.
    Liang, C.
    Tan, F.
    Harrow, K.
    Oertel, V.
    Dukart, G.
    Mok, T. S. K.
    [J]. ANNALS OF ONCOLOGY, 2017, 28
  • [8] eXalt3: A phase III study of ensartinib (X-396) in anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC).
    Horn, Leora
    Wu, Yi-Long
    Reck, Martin
    Liang, Chris
    Tan, Fenlai
    Harrow, Kimberly
    Oertel, Vance
    Dukart, Gary
    Mok, Tony
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Long Term Efficacy and Safety of Ensartinib in Pre-Treated Anaplastic Lymphoma Kinase (ALK) Positive Non-Small Cell Lung Cancer (NSCLC) Patients (eXalt2)
    Leal, T.
    Wakelee, H.
    Reckamp, K. L.
    Chiappori, A.
    Oxnard, G. R.
    Waqar, S. N.
    Patel, S. P.
    Blumenschein, G. R.
    Neal, J. W.
    Harrow, K.
    Holzhausen, A.
    Selvaggi, G.
    Zhou, J.
    Horn, L.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1171 - S1172
  • [10] The function and therapeutic targeting of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC)
    Golding, Brandon
    Luu, Anita
    Jones, Robert
    Viloria-Petit, Alicia M.
    [J]. MOLECULAR CANCER, 2018, 17
12345